Search results
Results from the WOW.Com Content Network
The reason is that several of these disorders include an issue with social communication. [19] In terms of developmental language disorder (DLD), individuals with this disorder have issues with language form and content and there seems to be no developmental cause. [19] In social environments, DLD seemed to have fewer difficulties than SPCD. [19]
Strauman (1989) investigated how emotional disorders shape a person's cognitive structure, that is, the mental processes people utilize to make sense of the world around them. [17] He recruited three groups of individuals: those with social phobias, those with depression, and controls with no emotional disorder diagnosis.
Wilhelm Reich first identified the phallic narcissistic personality type, with excessively inflated self-image. The individual is elitist, a "social climber", admiration seeking, self-promoting, bragging and empowered by social success.
Selective mutism (SM) is an anxiety disorder in which a person who is otherwise capable of speech becomes unable to speak when exposed to specific situations, specific places, or to specific people, one or multiple of which serve as triggers. This is caused by the freeze response. Selective mutism usually co-exists with social anxiety disorder. [1]
The Crown producer Left Bank Pictures is bringing a new true crime series called The Lady to ITV, which will tell the story of Jane Andrews — convicted killer and former dresser to the Duchess ...
The third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM III) divided conduct disorder into four subtypes: undersocialized-aggressive, undersocialized-nonaggressive, socialized-aggressive, and socialized-nonaggressive in an attempt to recognize the existence of psychopathic traits in children. [24]
However, the company’s strategy had changed. The rising sales numbers showed that Biederman’s evangelizing about conduct disorder had obviously encouraged pediatricians to dispense Risperdal. But it had not swayed the FDA. If the application extended the patent by a half-year, it could be worth as much as $1.5 billion in additional U.S. sales.
From January 2008 to December 2012, if you bought shares in companies when Claes Dahlbäck joined the board, and sold them when he left, you would have a -40.6 percent return on your investment, compared to a -2.8 percent return from the S&P 500.